.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 5,707,975

« Back to Dashboard

Claims for Patent: 5,707,975

Title: Oral formulations on an antifungal
Abstract:The present invention concerns a formulation for oral administration comprising an antifungal, a sufficient amount of a cyclodextrin or a derivative thereof, an aqueous acidic medium as bulk liquid carrier and an alcoholic co-solvent Addition of one or more pharmaceutically acceptable sweeteners and one or more pharmaceutically acceptable flavors thereto yields palatable oral formulations. A process of preparing such formulations and pharmaceutical dosage forms comprising said formulations.
Inventor(s): Fran.cedilla.ois; Marc Karel Jozef (Kalmthout, BE), Dries; Willy Maria Albert Carlo (Merksplas, BE)
Assignee: Janssen Pharmaceutica, N.V. (Beerse, BE)
Application Number:08/604,950
Patent Claims: 1. A formulation for oral administration comprising:

(a) itraconazole or saperconazole;

(b) a sufficient amount of a hydroxypropyl-.beta.-cyclodextrin having an M.S. in the range of 0.3 to 3 and containing less than 5% unsubstituted .beta.-cyclodextrin, to act as a solubilizer for the itraconazole or saperconazole;

(c) an aqueous acidic medium as bulk liquid carrier;

(d) from about 1% (v/v) to about 20% (v/v) of an alcoholic co-solvent selected from the group consisting of ethanol, propylene glycol and glycerol;

(e) one or more pharmaceutically acceptable intense sweeteners plus one or more bulk sweeteners; and

(f) one or more pharmaceutically acceptable flavors.

2. A formulation according to claim 1 wherein the cyclodextrin is hydroxypropyl-.beta.-cyclodextrin having an M.S. in the range of 0.35 to 0.50 and containing less than 1.5% unsubstituted .beta.-cyclodextrin.

3. A formulation according to claim 2 wherein the alcoholic co-solvent is propylene glycol.

4. A formulation according to claim 3 having a pH of 2.0.+-.0.1.

5. A formulation according to claim 4 wherein the intense sweetener is selected from the group consisting of saccharin, sodium or calcium saccharin and the bulk sweetener is selected from the group consisting of sorbitol, mannitol, fructose, sucrose, maltose, glucose, caramel or honey.

6. A formulation according to claim 1 comprising by weight or by volume based on the total volume of the formulation:

(a) 4% (w/v) itraconazole;

(b) 60% (w/v) hydroxypropyl-.beta.-cyclodextrin;

(c) 10% (v/v) propylene glycol;

(d) acid and base to adjust the pH of the composition within the range of 2.0.+-.0.1;

(e) 0.08% (w/v) sodium saccharin;

(f) up to 1% (w/v) of one or more flavours; and

(g) water.

7. A formulation according to claim 1 comprising by weight or by volume based on the total volume of the formulation:

(a) 1% (w/v) itraconazole or saperconazole;

(b) 40% (w/v) hydroxypropyl-.beta.-cyclodextrin;

(c) 10% (v/v) propyleneglycol;

(d) acid or base to adjust the pH of the composition within the range of 2.0.+-.0.1;

(e) 0.06% (w/v) sodium saccharin;

(f) 19% (v/v) sorbitol (70%) non-crystallizing solution;

(g) up to 1% (w/v) of one or more flavours;

(h) 0.02% (w/v) of a carmel sweetener; and

(i) water.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc